First Italian Conference on Pediatric DIPG/DMG 2023


Dr. Sabina Mueller

Neurology UCSF Weill Institute for Neurosciences · School of Medicine, University of California (San Francisco, California)

“New therapeutic approaches for children with DMG: a PNOC perspective”

Dr. Esther Hulleman

Departments Of Pediatric Oncology / Hematology, Neuro-Oncology Research Group, Cancer Center Amsterdam, VU University Medical Center (Amsterdam, The Netherlands)

“Towards Combinational Therapy For DMG” ​

Dr. Mark Mabanglo

Ontario Institute for Cancer Research/University of Toronto (Toronto, Canada)

“Development of novel anticancer compounds targeting mitochondrial ClpP and protein

Prof. Christof Kramm

Chief of Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Medical Center Goettingen (Goettingen, Germany)

“From German HIT-HGG trials to the new European trial SIOPE HGG-01: A long and stony way to improve the situation of pediatric DIPG/DMG patients” 

“Epigenetic targets and treatment approaches: What can we learn from H3.3K27M isogenic DIPG/DMG models?”


Dr. Angela Mastronuzzi

Head of the Neuro-Oncology Unit at the Pediatric Hospital Bambino Gesù in the Department of Hematology, Oncology, Cellular Therapy, Genetic Therapy and Hematopoietic Stem Cell Transplantation.

Dr. Andrea Carai

Ospedale Pediatrico Bambino Gesù (Rome, Italy)

“The Biopsy Dilemma: Balancing Benefits and Risks in DIPG Care”

Prof. Manila Antonelli

Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo-Patologiche, Università la

Sapienza (Rome, Italy)

“Histological and molecular approach to diagnosis of diffuse midline glioma H3K27- altered”

Prof. Antonio Ruggiero


Prof. Brigitte Bison

Diagnostic and interventional Neuroradiology, Faculty of Medicine, Department of

Neuroradiology, University Hospital of Augsburg (Augsburg, Germany)

“Neuroradiology in Diffuse Intrinsic Pontine Gliomas/ Diffuse Midline Gliomas”

Dr. Sabina Vennarini

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

“Re-Irradiazione of Pediatric Malignant Glioma”

Dr. Veronica Biassoni

Pediatria Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

“The SIOPe DIPG/DMG registry”

Prof. Marta Maria Alonso Roldàn

Medical Oncology Department, Universidad de Navarra (Spain)

“Oncolytic viruses for pediatric brain tumors: an alternative therapeutic approach”

Prof. Cosimo Fortuna

Department of Chemical Science, University of Catania (Italy)

“Fingerprints for Ligands and Proteins interaction investigation tackling hClpP”

Prof. Javad Nazarian

Head of DMG Research Center, University of Zurich (Zurich, Swiss)

“A multipronged approach for targeting tumor metabolism in pediatric high grade gliomas”

Dr. Elisabetta Schiavello

Pediatric Oncologic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

“Integration of oncological and palliative treatment in pediatric DIPG/DMG: are simultaneous care really feasible?

Prof. Antonio Scilimati

Associate Professor Of Medicinal Chemistry At The University Of Bari

Prof. Maria Grazia Perrone

Dr. Maura Massimino

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (Italy)

“Story of adjuvant treatment with nimotuzumab/vinorelbine in DIPG”

Dr. Mara Vinci

Paediatric High Grade Glioma Group, Ospedale Pediatrico Bambino Gesù (Rome, Italy)

“Exploiting mass cytometry for the immunophenotyping and the study of the TME in DIPG and other paediatric-type diffuse high-grade gliomas”

Dott.ssa Giorgia Frumenzio

Other speakers will also participate in the Congress, you can see all the names on the Official Program


The Congress is held in Bari, at the Chamber of Commerce in Corso Cavour 2, 70121 Bari BA.

You can find all our contacts by clicking on this Contatti 

On the website page called ‘Venue’ you can find all the information you are looking for, alternatively you can send us an email at

Registration is required to access the event, please fill out the contact form that you can find at this link

After registering, you will receive a confirmation email that you will need to present on-site on July 8th, from 8:30 am to 9:00 am at the Registration Point.